BCC
HRMY icon

Bridge City Capital’s Harmony Biosciences HRMY Stock Holding History

Bridge City Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62M Buy
+209,200
New +$6.6M 1.74% 15
2026
Q1 		– Sell
-237,103
Closed -$8.87M – 110
2025
Q4 		$8.87M Sell
237,103
-22,840
-9% -$751K 2.61% 2
2025
Q3 		$7.16M Buy
259,943
+97,279
+60% +$3.35M 1.91% 8
2025
Q2 		$5.14M Buy
162,664
+1,925
+1% +$61.9K 1.44% 23
2025
Q1 		$5.33M Buy
160,739
+56,930
+55% +$2.04M 1.6% 17
2024
Q4 		$3.57M Buy
103,809
+22,773
+28% +$782K 0.95% 39
2024
Q3 		$3.24M Buy
+81,036
New +$2.85M 0.89% 49

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridge City Capital's HRMY Position: Q2 2026 in Review

Bridge City Capital opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 209,200 shares worth $7.62M. The stake represents 1.74% of the portfolio and ranks #15 among its holdings. This is a return to the name: Bridge City Capital previously reported a position in HRMY as recently as Q4 2025.

Bridge City Capital first reported a position in HRMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $8.87M in Q4 2025. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Bridge City Capital held 209,200 shares of Harmony Biosciences worth $7.62M as of Q2 2026.
  • Harmony Biosciences was a new Bridge City Capital position in Q2 2026.
  • Harmony Biosciences made up 1.74% of Bridge City Capital's portfolio in Q2 2026, its #15 holding.
  • Bridge City Capital first reported a position in Harmony Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Bridge City Capital's Harmony Biosciences position peaked at $8.87M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Bridge City Capital's 13F filing for Q2 2026, filed 11 Aug 2026.